Shulei Fan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Shulei Fan has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Daqing Hong
School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
2 shared publications - Amanda Ying Wang
The Renal and Metabolic Division, The George Institute for Global Health, University of NSW, Sydney, Australia
1 shared publication - Chun Wu
Department of Cardiothoracic Surgery, Children’s Hospital of Chongqing Medical University , Chongqing
1 shared publication - Daoxin Wang
Department of Respiratory and Critical Care Medicine, the Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China
1 shared publication - Di Qi
Department of Respiratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, P. R. China
1 shared publication - Guisen Li
Department of Nephrology and Nephrology Institute, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
1 shared publication
Latest Publications
- Open Access
- 1 July 2026
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (7) , 718
Global, regional and national burden of chronic obstructive pulmonary disease and lower respiratory infection attributable to household air pollution and secondhand smoke from 1990 to 2021: an analysis of the Global Burden of Disease Study (GBD 2021)
Background: Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease that can be influenced by a multitude of factors. As the most significant cause of acute exacerbation of COPD, lower respiratory tract infections (LRIs) still result in a heavy global burden in 2021. The 1990-2021 period encapsulates major global shifts, including the energy transition from solid fuels to clean energy in emerging economies and the implementation of the World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC), making it crucial for public health analysis. This study aims to comprehensively evaluate the global, regional, and national burden of COPD and LRIs attributable to household air pollution (HAP) and secondhand smoke (SHS) from 1990 to 2021, and to project future trends using Global Burden of Disease Study 2021 (GBD 2021) data. Methods: We utilized data from GBD 2021, which provided estimates for 204 countries and territories from 1990 to 2021 using independently estimated population denominators derived from 2,026 data sources including censuses and vital registration systems. HAP was defined as exposure to particulate matter from solid fuel combustion (coal, wood, crop residues, or dung), and SHS was defined as involuntary exposure to tobacco smoke in indoor environments (at home, work, or public places). The Bayesian age-period-cohort (BAPC) and Autoregressive Integrated Moving Average (ARIMA) models were employed to project disease burden and evaluate the impact of HAP and SHS on attributable burden. Results: Globally, from 1990 to 2021, age-standardized disability-adjusted life years (DALYs) and age-standardized mortality rates (ASMRs) for COPD declined by 37.00% and 37.12%, respectively. The corresponding declines for lower respiratory infections (LRIs) were 66.35% and 53.62%, respectively. Despite global declines, the burden of COPD and LRI attributable to HAP and SHS remained disproportionately concentrated in low- and middle-income countries (LMICs), particularly among older females for COPD, children Conclusions: Persistently high disease burdens still exist among elderly populations and in LMICs. Importantly, HAP and SHS, as major indoor air pollution sources, contribute to the disease burden partially in a sex-specific manner. Otherwise, future COPD burden attributable to both HAP and SHS is projected to be greater in older females and surpass males by 2030. Key interventions include expanding vaccination, promoting clean cooking fuels, and prioritizing indoor air quality alongside tobacco control.
- 1 July 2026
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 18 (7) , 718
Open AccessGlobal, regional and national burden of chronic obstructive pulmonary disease and lower respiratory infection attributable to household air pollution and secondhand smoke from 1990 to 2021: an analysis of the Global Burden of Disease Study (GBD 2021)
Background: Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease that can be influenced by a multitude of factors. As the most significant cause of acute exacerbation of COPD, lower respiratory tract infections (LRIs) still result in a heavy global burden in 2021. The 1990-2021 period encapsulates major global shifts, including the energy transition from solid fuels to clean energy in emerging economies and the implementation of the World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC), making it crucial for public health analysis. This study aims to comprehensively evaluate the global, regional, and national burden of COPD and LRIs attributable to household air pollution (HAP) and secondhand smoke (SHS) from 1990 to 2021, and to project future trends using Global Burden of Disease Study 2021 (GBD 2021) data. Methods: We utilized data from GBD 2021, which provided estimates for 204 countries and territories from 1990 to 2021 using independently estimated population denominators derived from 2,026 data sources including censuses and vital registration systems. HAP was defined as exposure to particulate matter from solid fuel combustion (coal, wood, crop residues, or dung), and SHS was defined as involuntary exposure to tobacco smoke in indoor environments (at home, work, or public places). The Bayesian age-period-cohort (BAPC) and Autoregressive Integrated Moving Average (ARIMA) models were employed to project disease burden and evaluate the impact of HAP and SHS on attributable burden. Results: Globally, from 1990 to 2021, age-standardized disability-adjusted life years (DALYs) and age-standardized mortality rates (ASMRs) for COPD declined by 37.00% and 37.12%, respectively. The corresponding declines for lower respiratory infections (LRIs) were 66.35% and 53.62%, respectively. Despite global declines, the burden of COPD and LRI attributable to HAP and SHS remained disproportionately concentrated in low- and middle-income countries (LMICs), particularly among older females for COPD, children Conclusions: Persistently high disease burdens still exist among elderly populations and in LMICs. Importantly, HAP and SHS, as major indoor air pollution sources, contribute to the disease burden partially in a sex-specific manner. Otherwise, future COPD burden attributable to both HAP and SHS is projected to be greater in older females and surpass males by 2030. Key interventions include expanding vaccination, promoting clean cooking fuels, and prioritizing indoor air quality alongside tobacco control.
- Open Access
- 1 January 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 5475832
Adipose‐Derived Circulating Exosomes Promote Protection of the Pulmonary Endothelial Barrier by Inhibiting EndMT and Oxidative Stress through Down‐Regulation of the TGF‐β Pathway: A Potential Explanation for the Obesity Paradox in ARDS
The “obesity paradox in acute respiratory distress syndrome” (ARDS) refers to the phenomenon in which obesity is associated with higher morbidity but lower mortality in patients with ARDS. Endothelial‐to‐mesenchymal transition (EndMT) represents a key link in the interaction between endothelial disruption and mesenchymal fibrosis under inflammatory and oxidative conditions, which represent the intersectional pathophysiology of ARDS. Adipose tissue is considered to constitute the major source of circulating exosomal microRNAs (miRNAs), which act as genetic forms of adipokines for cell–cell crosstalk. We aimed to demonstrate the regulation and mechanism of adipose‐derived exosomes in the obesity paradox in ARDS. High‐fat‐induced obese mice and lean control mice were subjected to ARDS insult to investigate the effects of obesity on ARDS and microarray analysis was performed to screen for differences in circulating miRNAs. In addition, mice and pulmonary endothelial cells were administered with adipose‐derived exosomal miR‐122‐5p to investigate the underlying molecular mechanisms. We found high‐fat diet‐induced obesity protected against ARDS in mice by reinforcing endothelial barrier and attenuating fibroproliferation. Circulating exosomes produced in the obese state mediated these protective effects by inhibiting EndMT and oxidative stress. Mechanistically, adipose‐derived exosomal miR‐122‐5p promoted the integrity and function of pulmonary endothelial barrier and alleviated fibrogenesis by suppressing EndMT and oxidative stress through down‐regulation of the transforming growth factor β1 (TGF‐β1)/TGF‐β receptor 1 (TGF‐βR1)/Smad2 pathway in vivo and in vitro. In conclusion, adipose‐derived circulating exosomal miR‐122‐5p protects against ARDS by reinforcing pulmonary endothelial barrier through inhibition of EndMT and oxidative stress via down‐regulation of the TGF‐β pathway, which propose a potential explanation for the obesity paradox in ARDS and indicate promising prospects for adipose‐derived exosomes in cell‐free therapies for ARDS.
- 1 January 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 5475832
Open AccessAdipose‐Derived Circulating Exosomes Promote Protection of the Pulmonary Endothelial Barrier by Inhibiting EndMT and Oxidative Stress through Down‐Regulation of the TGF‐β Pathway: A Potential Explanation for the Obesity Paradox in ARDS
The “obesity paradox in acute respiratory distress syndrome” (ARDS) refers to the phenomenon in which obesity is associated with higher morbidity but lower mortality in patients with ARDS. Endothelial‐to‐mesenchymal transition (EndMT) represents a key link in the interaction between endothelial disruption and mesenchymal fibrosis under inflammatory and oxidative conditions, which represent the intersectional pathophysiology of ARDS. Adipose tissue is considered to constitute the major source of circulating exosomal microRNAs (miRNAs), which act as genetic forms of adipokines for cell–cell crosstalk. We aimed to demonstrate the regulation and mechanism of adipose‐derived exosomes in the obesity paradox in ARDS. High‐fat‐induced obese mice and lean control mice were subjected to ARDS insult to investigate the effects of obesity on ARDS and microarray analysis was performed to screen for differences in circulating miRNAs. In addition, mice and pulmonary endothelial cells were administered with adipose‐derived exosomal miR‐122‐5p to investigate the underlying molecular mechanisms. We found high‐fat diet‐induced obesity protected against ARDS in mice by reinforcing endothelial barrier and attenuating fibroproliferation. Circulating exosomes produced in the obese state mediated these protective effects by inhibiting EndMT and oxidative stress. Mechanistically, adipose‐derived exosomal miR‐122‐5p promoted the integrity and function of pulmonary endothelial barrier and alleviated fibrogenesis by suppressing EndMT and oxidative stress through down‐regulation of the transforming growth factor β1 (TGF‐β1)/TGF‐β receptor 1 (TGF‐βR1)/Smad2 pathway in vivo and in vitro. In conclusion, adipose‐derived circulating exosomal miR‐122‐5p protects against ARDS by reinforcing pulmonary endothelial barrier through inhibition of EndMT and oxidative stress via down‐regulation of the TGF‐β pathway, which propose a potential explanation for the obesity paradox in ARDS and indicate promising prospects for adipose‐derived exosomes in cell‐free therapies for ARDS.
- Open Access
- 18 March 2019
- Published by Springer Nature in BMC Nephrology
- Vol. 20 (1) , 1-8
Hyperuricemia and its related histopathological features on renal biopsy
Hyperuricemia (HUA) is very common in chronic kidney disease (CKD). HUA is associated with an increased risk of cardiovascular events and accelerates the progression of CKD. Our study aimed to explore the relationship between baseline serum uric acid levels and renal histopathological features. One thousand seventy patients receiving renal biopsy in our center were involved in our study. The baseline characteristics at the time of the kidney biopsy were collected from Renal Treatment System (RTS) database, including age, gender, serum uric acid (UA), glomerular filtration rate (eGFR), serum creatinine (Cr), urea, albumin (Alb), 24 h urine protein quantitation (24 h-u-pro) and blood pressure (BP). Pathological morphological changes were evaluated by two pathologists independently. Statistical analysis was done using SPSS 21.0. Among 1070 patients, 429 had IgA nephropathy (IgAN), 641 had non-IgAN. The incidence of HUA was 38.8% (n = 415), 43.8% (n = 188), and 43.2% (n = 277) in all patients, patients with IgAN and non-IgAN patients, respectively. Serum uric acid was correlated with eGFR (r = − 0.418, p < 0.001), Cr (r = 0.391, p < 0.001), urea (r = 0.410, p < 0.001), 24-u-pro (r = 0.077, p = 0.022), systolic blood pressure (SBP) (r = 0.175, p < 0.001) and diastolic blood pressure (DBP) (r = 0.109, p = 0.001). Multivariate logistic regression analysis showed that after adjustment for Cr, age and blood pressure, HUA was a risk factor for segmental glomerulosclerosis (OR = 1.800, 95% CI:1.309–2.477) and tubular atrophy/interstitial fibrosis (OR = 1.802, 95% CI:1.005–3.232). HUA increased the area under curve (AUC) in diagnosis of segmental glomerulosclerosis. Hyperuricemia is prevalent in CKD. The serum uric acid level correlates not only with clinical renal injury indexes, but also with renal pathology. Hyperuricemia is an independent risk factor for segmental glomerulosclerosis and tubular atrophy/interstitial fibrosis.
- 18 March 2019
- Published by Springer Nature in BMC Nephrology
- Vol. 20 (1) , 1-8
Open AccessHyperuricemia and its related histopathological features on renal biopsy
Hyperuricemia (HUA) is very common in chronic kidney disease (CKD). HUA is associated with an increased risk of cardiovascular events and accelerates the progression of CKD. Our study aimed to explore the relationship between baseline serum uric acid levels and renal histopathological features. One thousand seventy patients receiving renal biopsy in our center were involved in our study. The baseline characteristics at the time of the kidney biopsy were collected from Renal Treatment System (RTS) database, including age, gender, serum uric acid (UA), glomerular filtration rate (eGFR), serum creatinine (Cr), urea, albumin (Alb), 24 h urine protein quantitation (24 h-u-pro) and blood pressure (BP). Pathological morphological changes were evaluated by two pathologists independently. Statistical analysis was done using SPSS 21.0. Among 1070 patients, 429 had IgA nephropathy (IgAN), 641 had non-IgAN. The incidence of HUA was 38.8% (n = 415), 43.8% (n = 188), and 43.2% (n = 277) in all patients, patients with IgAN and non-IgAN patients, respectively. Serum uric acid was correlated with eGFR (r = − 0.418, p < 0.001), Cr (r = 0.391, p < 0.001), urea (r = 0.410, p < 0.001), 24-u-pro (r = 0.077, p = 0.022), systolic blood pressure (SBP) (r = 0.175, p < 0.001) and diastolic blood pressure (DBP) (r = 0.109, p = 0.001). Multivariate logistic regression analysis showed that after adjustment for Cr, age and blood pressure, HUA was a risk factor for segmental glomerulosclerosis (OR = 1.800, 95% CI:1.309–2.477) and tubular atrophy/interstitial fibrosis (OR = 1.802, 95% CI:1.005–3.232). HUA increased the area under curve (AUC) in diagnosis of segmental glomerulosclerosis. Hyperuricemia is prevalent in CKD. The serum uric acid level correlates not only with clinical renal injury indexes, but also with renal pathology. Hyperuricemia is an independent risk factor for segmental glomerulosclerosis and tubular atrophy/interstitial fibrosis.
- 1 November 2018
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 53 (11) , 2299-2306
Changes in resting pulmonary function testing over time after the Nuss procedure: A systematic review and meta-analysis
- 1 November 2018
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 53 (11) , 2299-2306
Changes in resting pulmonary function testing over time after the Nuss procedure: A systematic review and meta-analysis